Patents Assigned to Med Progress, LLC
  • Publication number: 20240123041
    Abstract: The present disclosure discloses compositions comprising a hyaluronidase, devices comprising such compositions, as well as methods and uses employing such compositions and devices to reduce or eliminate a hyaluronic acid-induced blockage of one or more blood vessels supplying an eye of an individual; methods and uses for employing such compositions and devices to reduce or inhibit a vascular occlusion in an eye of an individual; and methods and uses for employing such compositions and devices to reduce or inhibit a hyaluronic acid-induced loss of vision of an individual.
    Type: Application
    Filed: December 21, 2023
    Publication date: April 18, 2024
    Applicant: Med Progress, LLC
    Inventor: Steve Yoelin
  • Patent number: 11890331
    Abstract: The present disclosure discloses compositions comprising a hyaluronidase, devices comprising such compositions, as well as methods and uses employing such compositions and devices to reduce or eliminate a hyaluronic acid-induced blockage of one or more blood vessels supplying an eye of an individual; methods and uses for employing such compositions and devices to reduce or inhibit a vascular occlusion in an eye of an individual; and methods and uses for employing such compositions and devices to reduce or inhibit a hyaluronic acid-induced loss of vision of an individual.
    Type: Grant
    Filed: August 5, 2021
    Date of Patent: February 6, 2024
    Assignee: Med Progress, LLC
    Inventor: Steve Yoelin
  • Patent number: 11878051
    Abstract: The present disclosure discloses compositions comprising a hyaluronidase, devices comprising such compositions, as well as methods and uses employing such compositions and devices to reduce or eliminate a hyaluronic acid-induced blockage of one or more blood vessels supplying an eye of an individual; methods and uses for employing such compositions and devices to reduce or inhibit a vascular occlusion in an eye of an individual; and methods and uses for employing such compositions and devices to reduce or inhibit a hyaluronic acid-induced loss of vision of an individual.
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: January 23, 2024
    Assignee: Med Progress, LLC
    Inventor: Steve Yoelin
  • Publication number: 20210361752
    Abstract: The present disclosure discloses compositions comprising a hyaluronidase, devices comprising such compositions, as well as methods and uses employing such compositions and devices to reduce or eliminate a hyaluronic acid-induced blockage of one or more blood vessels supplying an eye of an individual; methods and uses for employing such compositions and devices to reduce or inhibit a vascular occlusion in an eye of an individual; and methods and uses for employing such compositions and devices to reduce or inhibit a hyaluronic acid-induced loss of vision of an individual.
    Type: Application
    Filed: August 5, 2021
    Publication date: November 25, 2021
    Applicant: Med Progress, LLC
    Inventor: Steve Yoelin
  • Publication number: 20210308234
    Abstract: The present disclosure discloses compositions comprising a hyaluronidase, devices comprising such compositions, as well as methods and uses employing such compositions and devices to reduce or eliminate a hyaluronic acid-induced blockage of one or more blood vessels supplying an eye of an individual; methods and uses for employing such compositions and devices to reduce or inhibit a vascular occlusion in an eye of an individual; and methods and uses for employing such compositions and devices to reduce or inhibit a hyaluronic acid-induced loss of vision of an individual.
    Type: Application
    Filed: April 2, 2021
    Publication date: October 7, 2021
    Applicant: Med Progress, LLC
    Inventor: Steve Yoelin